Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Hadeel Khallouf, PhD

Postdoctoral Scientist


Scientific CV

2012 - 2015
Postdoctoral scientist, Junior Research Group Immunotherapy and Immunoprevention, DKFZ, Heidelberg

2007 - 2011                       
PhD in Oncology, National Center for Tumor Diseases and University Hospital Heidelberg, Heidelberg

2005 - 2007                       
MSc in Pharmacology, Faculty of Pharmacy, University of Strasbourg, Strasbourg, France

1999 - 2004
BSc in Pharmacy and Pharmaceutical Chemistry, University of Damascus, Syria

Research Project

Development of optimal formulation and delivery systems for epitope-based therapeutic HPV vaccines

Therapeutic vaccination with defined epitopes is an attractive approach for induction of HPV-specific T lymphocyte responses. We are working with HPV epitopes that have been proven to be presented on HPV-transformed tumor cells by our highly sensitive mass spectrometry approach. This project dealt with establishing and evaluating various vaccine delivery and adjuvant formulations to determine the best vaccination methodology for targeted induction of effective anti-HPV immune responses.

Resulting Publications

Therapeutic vaccine strategies against HPV.
Khallouf H, Grabowska AK, Riemer AB.
Vaccines 2014, 2(2): 422-462.

to top
powered by webEdition CMS